Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Evolva
company
About
Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.
- 101 - 250
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €12M
- Industries
- Biotechnology,Food and Beverage,Health Care,Wellness
- Founded date
- Jan 1, 2004
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients. Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small-molecule drugs and other compounds. In particular, their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches.The company is headquartered in Reinach, Switzerland.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
€14M $37.80M Fr28M
Evolva has raised a total of
€14M $37.80M Fr28M
in funding over 2 rounds. Their latest funding was raised on
Dec 11, 2009 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 11, 2009 | Post-IPO Equity | $27.50M | 1 | — | — | Detail |
| Oct 22, 2009 | Series B | Fr28M | 1 | — | — | Detail |
| Dec 1, 2006 | Series A | $10.30M | 2 | — | — | Detail |
| Mar 21, 2005 | Series A | €2M | 2 | — | — | Detail |
| Aug 16, 2004 | Series A | €12M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Evolva is funded by 2 investors.
Dansk Innovation
and Yamanouchi Venture Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Equity |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
